Baidu
map

2019 韩国间质性肺病诊断和管理指南:特发性间质纤维化

2019-02-28 韩国结核和呼吸疾病学会 Tuberc Respir Dis (Seoul). 2019 Feb 28.

2019年2月,韩国结核和呼吸疾病学会(KATRD)发布了特发性间质纤维化的诊断和管理指南,特发性肺纤维化(IPF)是一种慢性,渐进性纤维化间质性肺炎,主要表现为进行性呼吸困难恶化,通常预后较差。本文主要针对特发性间质纤维化的管理提出指导建议,内容涉及流行病学,病理学,危险因素,临床标准,诊断,治疗以及预后等。

中文标题:

2019 韩国间质性肺病诊断和管理指南:特发性间质纤维化

英文标题:

Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Interstitial Fibrosis.

发布日期:

2019-02-28

简要介绍:

2019年2月,韩国结核和呼吸疾病学会(KATRD)发布了特发性间质纤维化的诊断和管理指南,特发性肺纤维化(IPF)是一种慢性,渐进性纤维化间质性肺炎,主要表现为进行性呼吸困难恶化,通常预后较差。本文主要针对特发性间质纤维化的管理提出指导建议,内容涉及流行病学,病理学,危险因素,临床标准,诊断,治疗以及预后等。 

拓展指南:肺纤维化相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 韩国间质性肺病诊断和管理指南:特发性间质纤维化)] GetToolGuiderByIdResponse(projectId=1, id=d28b51c001e16a49, title=2019 韩国间质性肺病诊断和管理指南:特发性间质纤维化, enTitle=Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Interstitial Fibrosis., guiderFrom=Tuberc Respir Dis (Seoul). 2019 Feb 28., authorId=null, author=, summary=2019年2月,韩国结核和呼吸疾病学会(KATRD)发布了特发性间质纤维化的诊断和管理指南,特发性肺纤维化(IPF)是一种慢性,渐进性纤维化间质性肺炎,主要表现为进行性呼吸困难恶化,通常预后较差。本文主要针对特发性间质纤维化的管理提出指导建议,内容涉及流行病学,病理学,危险因素,临床标准,诊断,治疗以及预后等。 , cover=, journalId=null, articlesId=null, associationId=1675, associationName=韩国结核和呼吸疾病学会, associationIntro=, copyright=0, guiderPublishedTime=Thu Feb 28 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年2月,韩国结核和呼吸疾病学会(KATRD)发布了特发性间质纤维化的诊断和管理指南,特发性肺纤维化(IPF)是一种慢性,渐进性纤维化间质性肺炎,主要表现为进行性呼吸困难恶化,通常预后较差。本文主要针对特发性间质纤维化的管理提出指导建议,内容涉及流行病学,病理学,危险因素,临床标准,诊断,治疗以及预后等。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>肺纤维化</font>相关指南:</strong><br><ul><li><a href="//m.sandwebs.com/guideline/show_article.do?id=7caf01c001682883" title="特发性肺纤维化诊断临床指南(摘译)" target=_blank>特发性肺纤维化诊断临床指南(摘译)</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=2c7d21c0016e6a05" title="Fleischner学会关于特发性肺纤维化诊断标准的白皮书解读" target=_blank>Fleischner学会关于特发性肺纤维化诊断标准的白皮书解读</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=7c0f41c0016ae5ab" title="2018 ITS立场声明:特发性肺纤维化的管理" target=_blank>2018 ITS立场声明:特发性肺纤维化的管理</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=f484b1c00162e074" title="2018 特发性肺纤维化的评估和管理建议" target=_blank>2018 特发性肺纤维化的评估和管理建议</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=64f7d1c001613a34" title="2018 日本特发性肺纤维化治疗指南" target=_blank>2018 日本特发性肺纤维化治疗指南</a></li> 更多信息请点击:<a href="//m.sandwebs.com/guideline/list.do?q=%E8%82%BA%E7%BA%A4%E7%BB%B4%E5%8C%96" target=_blank>有关肺纤维化更多指南</a></ul>, tagList=[TagDto(tagId=88083, tagName=特发性间质纤维化)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6237, appHits=252, showAppHits=0, pcHits=4050, showPcHits=3372, likes=93, shares=15, comments=1, approvalStatus=1, publishedTime=Sun Mar 24 11:47:58 CST 2019, publishedTimeString=2019-02-28, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Mar 24 11:47:58 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 16:46:15 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 韩国间质性肺病诊断和管理指南:特发性间质纤维化)])
2019 韩国间质性肺病诊断和管理指南:特发性间质纤维化
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2106647, encodeId=760f210664e7e, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e105594458, createdName=ms9000001816126049, createdTime=Mon Dec 19 11:30:46 CST 2022, time=2022-12-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=380835, encodeId=def63808355f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Sun Mar 22 14:46:24 CST 2020, time=2020-03-22, status=1, ipAttribution=)]
    2022-12-19 ms9000001816126049 来自河南省

    1

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2106647, encodeId=760f210664e7e, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e105594458, createdName=ms9000001816126049, createdTime=Mon Dec 19 11:30:46 CST 2022, time=2022-12-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=380835, encodeId=def63808355f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Sun Mar 22 14:46:24 CST 2020, time=2020-03-22, status=1, ipAttribution=)]
    2020-03-22 thm112988

    0

Baidu
map
Baidu
map
Baidu
map